Eeyarestatin I (ESI)-induced ERAD inhibition exhibits anti-cancer activity through multiple mechanisms in human colorectal cancer cells
Author:
Jing Peng,Cheng-I Wei,Seong-Ho Lee
Publication:
European Journal of Pharmacology
© 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.